ADDIS ABABA, Ethiopia and PLYMOUTH MEETING, Pa., Aug. 28, 2019 /PRNewswire/ -- A collaborative project from the National Comprehensive Cancer Network® (NCCN&r

CHICAGO, Aug. 28, 2019 /PRNewswire/ -- The National Council of State Boards of Nursing (NCSBN®), www.ncsbn.org, inducted its 13th group of Fellows of the NCSBN Institute o

PHILADELPHIA, Aug. 28, 2019 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Sinotherapeutics Inc., a China-based specialty pharmaceutical company, to be the exclusive U.S. distributor of Posaconazole Delayed-Release Tablets 100mg.  Sinotherapeutics has received

PLANO, Texas, Aug. 28, 2019 /PRNewswire/ -- On Tuesday a group of leaders from Life Skills Autism Academy and the Plano Chamber of Commerce gathered to celebrate the opening of a new center offering high quality early intensive Applied Behavioral Analysis (ABA) therapy to help young children with Autism Spectrum Disorder (ASD) acquir

LAS VEGAS, Aug. 28, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) today announced the appointment to GB Sciences' executive team of Darin Carpenter as the company's new Executive Vice President for Operations and General Manager, bringing his extensive and nationally-recognized experience streamlining production, improving produ

FERNANDINA BEACH, Fla., Aug. 28, 2019 /PRNewswire/ -- Ponce De Leon Health, a commercial stage company focused on reversing epigenetic aging, today announced the launch of

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- April – JuneSignificant events during the quarterSelective effect signal on liver cancer tissue in phase Ia study with MIV-818. The analysis shows an early indication that MIV-818 works as expected, i.e. the substance has the intended liver-directed effect. New dat

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- Summary Financial overview April 1 – June 30, 2019 Net sales amounted to SEK 0.0 M (0.0) Loss for the period was SEK 171.9 M (loss: 144.6)

STOCKHOLM, Aug. 28, 2019 /PRNewswire/ -- IRLAB (Nasdaq First North Premier: IRLAB A) today announced that the in-depth analysis of the data from the recently concluded Phase IIa study of IRL790 in Parkinson's patients with L-dopa induced dyskinesia (LIDs) brings further evidence of the drug candidate's ability to significantly and meaningfully improve daytime m

SAN DIEGO, Aug. 27, 2019 /PRNewswire/ -- CBD Nationwide, the nation's most respected and largest in-house CBD manufacturer, has expanded operations and facilities. The new proprietary machinery